Dong, M., Koole, C., Wootten, D., Sexton, P
GLP-1 medications, often used to manage weight and diabetes, are creating big shifts in what people eat and drink
For readers interested in the science backing this approach, see the CDCs data showing that in 2024, 26.5% of adults with diabetes were using GLP-1 injectables, with adoption highest among those aged 5064 (further reading)
These tests are not included in Henrys costs
By taking the time to understand what compounded semaglutide is mixed with and the potential risks involved, you can make more informed choices for your weight loss journey